Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Cespedes Guachamboza, Carlos Milton

Cespedes Guachamboza, Carlos Milton

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca
Cespedes Guachamboza, Carlos Milton

Cespedes Guachamboza, Carlos Milton

Cespedes Guachamboza, Carlos Milton

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Ma Lluisa Torrent Bertran

Ma Lluisa Torrent Bertran

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Neus Castells Sarret

Neus Castells Sarret

Postdoctoral researcher
Genetics Medicine
Read more
Jorge Lugo Marin

Jorge Lugo Marin

Research technician
Psychiatry, Mental Health and Addictions
Read more
Jesus Trejo Zaminos

Jesus Trejo Zaminos

Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.